Surgical thoracic duct decompression: The right choice for Fontan-associated protein-losing enteropathy?
-
By
-
April 6, 2026
-
1 min
By
April 6, 2026
by
April 6, 2026
The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.
May 29, 2026